|
|
||||||||
Clinical Chemistry, Vol 18, 391-392, Copyright © 1972 by the American Association for Clinical Chemistry
1 Department of Pathology (Oncology), Tufts University School of Medicine, the Cancer Research Department,
New England Medical Center Hospitals; and the Enzymology
Laboratory, Lemuel Shattuck Hospital, Boston, Mass. 02130.
A quality-control program, in which a heat-stable human alkaline phosphatase preparation is used to monitor the performance of an automated alkaline phosphatase method, was observed for a year. In the method phenyl phosphate is used as substrate, L-phenylalanine as an intestinal isoenzyme inhibitor, and a phenol standard curve to monitor chromogen formation. Mean total alkaline phosphatase activity was 14.0 ± 0.9 King-Armstrong units (CV, 6.4%), and mean inhibition by L-phenylalanine was 78.2 ± 1.1% (CV, 1.4%). These data compared closely with the data obtained in a collaborating laboratory during the same one-year period.
Submitted on November 3, 1971
Accepted on December 13, 1971
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |